Description
SMab?
Target
SIGLEC5
Target Alias Names
CD170, OBBP2, CD33L2, OB-BP2, SIGLEC-5
Isotype/Mimetic
IgG
Animal-Derived Biomaterials Used
BSA
Sequence Available
No
Original Discovery Method
Immunisation post 2020 (on-going during disocvery but recombinant expression downstream)
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation